Evidence map›Paper›PMID 25228947›Full record

ArticleWorld journal of gastrointestinal endoscopy2014

Cyanoacrylate spray as treatment in difficult-to-manage gastrointestinal bleeding.

Liz Toapanta-Yanchapaxi, Norberto Chavez-Tapia, Félix Téllez-Ávila

Open access · hybridAbstract readCase Reports
In one paragraph

Article in World journal of gastrointestinal endoscopy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Liz Toapanta-YanchapaxiLiz Toapanta-Yanchapaxi, Norberto Chavez-Tapia, Gastroenterology Service, Digestive Disease and Obesity Clinic, Medica Sur Clinic and Foundation, Mexico City 14050, Mexico.
Norberto Chavez-TapiaLiz Toapanta-Yanchapaxi, Norberto Chavez-Tapia, Gastroenterology Service, Digestive Disease and Obesity Clinic, Medica Sur Clinic and Foundation, Mexico City 14050, Mexico.
Félix Téllez-ÁvilaLiz Toapanta-Yanchapaxi, Norberto Chavez-Tapia, Gastroenterology Service, Digestive Disease and Obesity Clinic, Medica Sur Clinic and Foundation, Mexico City 14050, Mexico.
Hospital Médica Sur · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrointestinal bleeding can be a life-treating event that is managed with standard endoscopic therapy in the majority of cases. However, up to 5%-10% of patients may have persistent bleeding that does not respond to conventional measures. Several endoscopic treatment techniques have been proposed as strategies to control such cases, such as epinephrine injection, hemoclips or argon plasma coagulation, but there are certain clinical scenarios where it is difficult to achieve hemostasis even though adequate use of the available resources is made. Reasons for these failures can be associated with the lesion features, such as extent or location. The use of long-standing techniques in non-traditional scenarios, such as with cyanoacrylate for gastric varices sclerosis, has been reported with favorable results. Although new products such as TC-325 or Ankaferd Blood Stopper hemosprays may be useful, their formulations are not available worldwide. Here we present two clinical cases with very different scenarios of gastrointestinal bleeding, where the use of cyanoacrylate in spray had favorable results in uncommon indications. Cyanoacrylate used as a spray is a technique that can be used as an alternative method in emergent settings.

Indexed as

CyanoacrylateGastrointestinal bleedingHemostasisMexicoSpray

Identifiers

PMID25228947
PMCPMC4163727
OpenAlexW2092137401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.